Second annual report gives a transparent overview of Prime’s organizational makeup, highlights milestones along its journey

oncology insights Decoding Cancer: How Genetic and Genomic Testing Advance Treatment December 13, 2024 Scientists have made remarkable progress in understanding the thousands of genes inside our...

Latest edition of Prime Therapeutics Report spotlights seismic shift in how best to diagnose and manage transthyretin amyloid cardiomyopathy (ATTR-CM) and what it means for patients, providers and...

Perspectives Oncology Insights: First-in-class bladder cancer therapy and the Bacillus Calmette-Guérin (BCG) shortage Approximately 83,000 new bladder cancer cases are diagnosed in the U.S. in each...

publications Radiopharmaceutical discovery and use is gaining momentum March 14, 2025 Author: Abby Kim, PharmD, BCOP Introducing Abby Kim, PharmD, BCOP Abby Kim, a Board-Certified Oncology...

Diversity, equity and inclusion Our commitment to diversity, equity and inclusion (DEI) is rooted in our purpose and dedication to serving others. Breadcrumb Home Who we are Culture Diversity,...

Oncology Insights: Transformative treatment for small cell lung cancer After decades of research, a new treatment is emerging for this aggressive form of lung cancer. By: Simone Ndujiuba, PharmD,...

Commercial formularies Breadcrumb Home Other Navigation Pharmacy + Providers Commercial Formularies PrimeChoice Accord Formulary PrimeChoice Accord Formulary Updates NetResults A-Series...